Clinical Characteristics of Hepatitis B Virus Patients After Switching to Tenofovir Alafenamide Fumarate: A Retrospective Observational Study

Background Hepatitis B Virus (HBV) continues to be a significant global health problem despite vaccination programs and effective antiviral drugs. Aim Assess tenofovir alafenamide fumarate (TAF) as a new treatment modality in light of the clinical characteristics of HBV patients. Settings and design...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Abdullah S, Alothmani, Hammad S, Mogharbel, Mohammed, Albiladi, Hazeez, Babatin, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550005/
https://www.ncbi.nlm.nih.gov/pubmed/33062501
http://dx.doi.org/10.7759/cureus.10380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550005/
https://www.ncbi.nlm.nih.gov/pubmed/33062501
http://dx.doi.org/10.7759/cureus.10380

Ejemplares similares